1. Introduction

   • George Klein

   EditorialNotes Pages: 319 - 323

2. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)

   • Michael A. Nalesnik

   OriginalPaper Pages: 325 - 342

3. The role of immunosuppression in lymphoma formation

   • Israel Penn

   OriginalPaper Pages: 343 - 355

4. The molecular genetics of post-transplantation lymphoproliferative disorders

   • Daniel M. Knowles

   OriginalPaper Pages: 357 - 373

5. Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders

   • Tanzina Haque
   • Dorothy H. Crawford

   OriginalPaper Pages: 375 - 387

6. Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders

   • Martin Rowe
   • Gerald Niedobitek
   • Lawrence S. Young

   OriginalPaper Pages: 389 - 403

7. Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD

   • Giovanna Tosato
   • Julie Teruya-Feldstein
   • Elaine S. Jaffe

   OriginalPaper Pages: 405 - 423

8. Interferon-α and its effects on post-transplant lymphoproliferative disorders

   • Albert Faro

   OriginalPaper Pages: 425 - 436

9. The antiviral prophylaxis of post-transplant lymphoproliferative disorder

   • C. L. Davis

   OriginalPaper Pages: 437 - 453

10. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts

    • Richard J. O'Reilly
    • Trudy N. Small
    • Lidia Koulova

    OriginalPaper Pages: 455 - 491